FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...
As weight loss medications like Ozempic and Wegovy become increasingly popular, questions arise about whether the nation is approaching pea ...
Goldman has a buy rating and $325.40 price target on CSL's shares. This implies potential upside of 19% for investors over ...
Weight-loss and diabetes drugs reduced the risk of developing Alzheimer’s, an independent study published Monday showed. The ...
Those on Medicare aren't exempt from this. Original Medicare's cost and coverage change annually. This affects how much you pay and the type of supplementary insurance you may want. Ideally ...
A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.
In a report released on January 24, David Low from J.P. Morgan maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of ...
Before starting Zepbound a year ago, Klapper struggled with joint pain, sleep apnea, and other health issues. The mother of two young boys found it challenging to engage in play and activities ...